In Vitro Synergy and In Vivo Activity of Tigecycline-Ciprofloxacin Combination Therapy against Vibrio vulnificus Sepsis

The mortality rate associated with Vibrio vulnificus sepsis remains high. An in vitro time-kill assay revealed synergism between tigecycline and ciprofloxacin. The survival rate was significantly higher in mice treated with tigecycline plus ciprofloxacin than in mice treated with cefotaxime plus min...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Kim, Seong Eun, Kim, Hee Kyung, Choi, Su-Mi, Yu, Yohan, Kim, Uh Jin, Darboe, Kalifa Sanneh, Kang, Seung-Ji, Park, Kyung-Hwa, Kang, Gaeun, Kim, Young Ran, Rhee, Joon Haeng, Jung, Sook-In, Jang, Hee-Chang
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2019
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6761547/
https://ncbi.nlm.nih.gov/pubmed/31332060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00310-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars